Warfarin resistance: possibilities to solve this problem. A case report [PDF]
Journal of International Medical Research, 2022 Effective prevention of thromboembolism is essential for patients with mechanical prosthetic heart valves. For this group of patients, vitamin K antagonists (VKAs) remain the drug group of choice despite the widespread use of new anticoagulants in other ...
Halyna Mostbauer +3 more
doaj +2 more sources
One Rare Warfarin Resistance Case and Possible Mechanism Exploration [PDF]
Pharmacogenomics and Personalized Medicine, 2023 Li Zhao,1 Zhenguo Zhai,2 Pengmei Li1 1Pharmacy Department, China-Japan Friendship Hospital, Beijing, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, People’s Republic of ...
Zhao L, Zhai Z, Li P
doaj +2 more sources
Genetic Warfarin-Resistance Resulting in Surgery to Change a Prosthetic Valve [PDF]
European Journal of Case Reports in Internal Medicine, 2020 Warfarin is a readily available anticoagulant used worldwide in a variety of clinical scenarios. Patients who need more than 15 mg/day are considered to be warfarin resistant.
Jahanzeb Malik +4 more
doaj +2 more sources
Ascorbic acid-induced warfarin resistance after breast cancer surgery: a case report and literature review [PDF]
Frontiers in PharmacologyWarfarin is an anticoagulant that requires INR-based dosage adjustment. Ascorbic acid may impair warfarin effectiveness according to limited literature.
Pingfa Gao +4 more
doaj +2 more sources
A Chinese patient with cardiogenic stroke and warfarin resistance: a case report [PDF]
BMC NeurologyBackground Warfarin is the most commonly used oral anticoagulant drug in clinical practice due to its effective anticoagulant effect and low cost. Warfarin plays a crucial role in the anticoagulant treatment of patients with thrombotic diseases such as ...
Xiaoyan Du +6 more
doaj +2 more sources
An Unlikely Culprit of Hospital-Acquired Warfarin Resistance: A Case Report and Review of Literature [PDF]
International Medical Case Reports JournalArcole Brandon,1 Leonie Dupuis,1 Danich Qadir,2 Furrukh Malik3 1Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; 2Department of Medicine, Jefferson-Einstein Philadelphia Hospital, Philadelphia, PA, USA; 3Division of ...
Brandon A, Dupuis L, Qadir D, Malik F
doaj +2 more sources
Multidisciplinary management of refractory Kawasaki disease with bilateral giant coronary artery aneurysms and latent tuberculosis infection: a case report focusing on immune–coagulation–infection crosstalk [PDF]
Frontiers in ImmunologyBackgroundThe management of refractory Kawasaki disease (KD) with giant coronary artery aneurysms (CAAs) complicated by latent tuberculosis infection (LTBI) represents a formidable “triple challenge”: it requires balancing aggressive inflammation control
Bingqian Xue +6 more
doaj +2 more sources
Novel mutations in the VKORC1 gene of wild rats and mice – a response to 50 years of selection pressure by warfarin? [PDF]
BMC Genetics, 2009 Background Coumarin derivatives have been in world-wide use for rodent pest control for more than 50 years. Due to their retarded action as inhibitors of blood coagulation by repression of the vitamin K reductase (VKOR) activity, they are the ...
Jäkel Thomas +8 more
doaj +4 more sources
Warfarin resistance: interaction between warfarin and Eruca sativa L.
Swiss Medical Weekly, 2006 [Abstract Not Available]
M Goz, F Goz, O Cakir, B Aydinol, N Eren
doaj +3 more sources
Anticoagulation Therapies and microRNAs in Heart Failure [PDF]
BiomoleculesHeart Failure (HF) remains a major cause of mortality despite the advances in pharmacological treatment. Anticoagulation therapies, including Clopidogrel, Aspirin, Warfarin, and novel oral anticoagulants (NOACs) such as Apixaban, Rivaroxaban, Edoxaban ...
Lucia Spartano +2 more
doaj +2 more sources